AR008765A1 - Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del - Google Patents
Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto delInfo
- Publication number
- AR008765A1 AR008765A1 ARP970102432A ARP970102432A AR008765A1 AR 008765 A1 AR008765 A1 AR 008765A1 AR P970102432 A ARP970102432 A AR P970102432A AR P970102432 A ARP970102432 A AR P970102432A AR 008765 A1 AR008765 A1 AR 008765A1
- Authority
- AR
- Argentina
- Prior art keywords
- composite
- same
- peptide
- recombinant
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un péptido o un derivado, análogo o variante funcional del mismo, que modula el peso corporal sustancialmente por medio de modulacion de lautilizacion de la energía, un péptido recombinante o sintético del mismo, una secuencia nucleotídica yvector que la contiene, una célula huéspedtransformada, una composicion farmacéutica que contiene un compuesto de este tipo, un procedimiento para la preparacionde un compuesto de este tipo y el usode dicho compuesto en medicina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9611775.9A GB9611775D0 (en) | 1996-06-06 | 1996-06-06 | Novel compounds |
| GBGB9618540.0A GB9618540D0 (en) | 1996-09-05 | 1996-09-05 | Novel compounds |
| GBGB9703493.8A GB9703493D0 (en) | 1997-02-20 | 1997-02-20 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008765A1 true AR008765A1 (es) | 2000-02-23 |
Family
ID=27268305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102432A AR008765A1 (es) | 1996-06-06 | 1997-06-04 | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0912609A2 (es) |
| JP (1) | JP2000512137A (es) |
| KR (1) | KR20000016402A (es) |
| CN (1) | CN1221426A (es) |
| AR (1) | AR008765A1 (es) |
| AU (1) | AU3337297A (es) |
| BR (1) | BR9709529A (es) |
| CA (1) | CA2257240A1 (es) |
| CZ (1) | CZ397898A3 (es) |
| IL (1) | IL127153A0 (es) |
| NO (1) | NO985683D0 (es) |
| NZ (1) | NZ332879A (es) |
| PL (1) | PL330361A1 (es) |
| TR (1) | TR199802534T2 (es) |
| WO (1) | WO1997046585A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2335107C (en) | 1998-07-28 | 2010-01-19 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Leptin-mediated gene-induction |
| US7208572B2 (en) * | 1998-08-21 | 2007-04-24 | Albany Medical College | Leptin-related peptides |
| US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| AU782230B2 (en) * | 1999-09-22 | 2005-07-14 | Serono Genetics Institute S.A. | Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| WO2001090188A2 (en) | 2000-05-22 | 2001-11-29 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Receptor-based interaction trap |
| DE60237100D1 (de) | 2001-10-22 | 2010-09-02 | Amgen Inc | Verwendung von leptin zur behandlung von lipoatropr prädisposition gegenüber der behandlung |
| ATE390144T1 (de) | 2003-09-08 | 2008-04-15 | Serono Lab | Behandlung von fibrosen |
| EP2422807A3 (en) | 2004-02-11 | 2012-05-30 | Amylin Pharmaceuticals Inc. | Hybrid polypeptides with selectable properties |
| CA2585549A1 (en) | 2004-11-18 | 2006-05-26 | Vib Vzw | Novel type leptin receptor antagonist |
| US20090286723A1 (en) | 2005-02-11 | 2009-11-19 | Amylin Pharmaceuticals, Inc. | Hybrid Polypeptides with Selectable Properties |
| KR20070115947A (ko) | 2005-02-11 | 2007-12-06 | 아밀린 파마슈티칼스, 인크. | 선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드 |
| US7629315B2 (en) | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
| BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
| ES2319048B1 (es) * | 2007-06-20 | 2010-02-10 | Universitat De Les Illes Balears | Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios. |
| US8889622B2 (en) | 2007-07-25 | 2014-11-18 | Washington University | Methods of inhibiting seizure in a subject |
| GB2451858A (en) * | 2007-08-15 | 2009-02-18 | Sergiy Konovchuk | Methods of reducing body fat and treating obesity |
| JP2011506294A (ja) | 2007-12-05 | 2011-03-03 | アストラゼネカ アクチボラグ | 抗肥満薬としてのピペラジン |
| CA2707248A1 (en) | 2007-12-05 | 2009-06-11 | Astrazeneca Ab | New compounds ii |
| MX2010013355A (es) * | 2008-06-04 | 2010-12-21 | Astrazeneca Ab | Nuevos compuestos v. |
| WO2009147216A1 (en) * | 2008-06-04 | 2009-12-10 | Biovitrum Ab (Publ) | New pyridine derivatives as leptin receptor modulator mimetics |
| JP2012523434A (ja) | 2009-04-10 | 2012-10-04 | アミリン・ファーマシューティカルズ，インコーポレイテッド | エストロゲン欠乏哺乳類のためのアミリンアゴニスト化合物 |
| ES2602436T3 (es) * | 2010-05-11 | 2017-02-21 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Inhibidor basado en péptido de la activación de interleucina 10 o STAT-3 |
| BR112013007388B1 (pt) | 2010-09-28 | 2022-01-04 | Amylin Pharmaceuticals, Llc | Polipeptídeo tendo domínio de ligação de albumina e leptina, seu uso no tratamento de doenças, bem como composição farmacêutica que o compreende |
| CN104829707B (zh) * | 2015-05-06 | 2017-12-19 | 广东省生物资源应用研究所 | 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用 |
| CN110183530A (zh) * | 2019-06-21 | 2019-08-30 | 深圳市亚辉龙生物科技股份有限公司 | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5552523A (en) * | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| WO1996023815A1 (en) * | 1995-01-31 | 1996-08-08 | Eli Lilly And Company | Ob gene product antibodies |
| CA2211656A1 (en) * | 1995-01-31 | 1996-08-08 | Margret B. Basinski | Anti-obesity proteins |
| WO1996031526A1 (en) * | 1995-04-06 | 1996-10-10 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
| GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-06-04 NZ NZ332879A patent/NZ332879A/xx not_active IP Right Cessation
- 1997-06-04 EP EP97929156A patent/EP0912609A2/en not_active Withdrawn
- 1997-06-04 AU AU33372/97A patent/AU3337297A/en not_active Abandoned
- 1997-06-04 BR BR9709529A patent/BR9709529A/pt not_active Application Discontinuation
- 1997-06-04 CN CN97195311A patent/CN1221426A/zh active Pending
- 1997-06-04 AR ARP970102432A patent/AR008765A1/es unknown
- 1997-06-04 KR KR1019980709976A patent/KR20000016402A/ko not_active Application Discontinuation
- 1997-06-04 PL PL97330361A patent/PL330361A1/xx unknown
- 1997-06-04 CZ CZ983978A patent/CZ397898A3/cs unknown
- 1997-06-04 TR TR1998/02534T patent/TR199802534T2/xx unknown
- 1997-06-04 WO PCT/EP1997/002968 patent/WO1997046585A2/en not_active Application Discontinuation
- 1997-06-04 IL IL12715397A patent/IL127153A0/xx unknown
- 1997-06-04 CA CA002257240A patent/CA2257240A1/en not_active Abandoned
- 1997-06-04 JP JP10500240A patent/JP2000512137A/ja active Pending
-
1998
- 1998-12-04 NO NO985683A patent/NO985683D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO985683L (no) | 1998-12-04 |
| WO1997046585A3 (en) | 1998-04-23 |
| KR20000016402A (ko) | 2000-03-25 |
| NO985683D0 (no) | 1998-12-04 |
| WO1997046585A2 (en) | 1997-12-11 |
| NZ332879A (en) | 2000-09-29 |
| EP0912609A2 (en) | 1999-05-06 |
| AU3337297A (en) | 1998-01-05 |
| PL330361A1 (en) | 1999-05-10 |
| BR9709529A (pt) | 1999-08-10 |
| TR199802534T2 (xx) | 1999-03-22 |
| CN1221426A (zh) | 1999-06-30 |
| CA2257240A1 (en) | 1997-12-11 |
| CZ397898A3 (cs) | 1999-04-14 |
| IL127153A0 (en) | 1999-09-22 |
| JP2000512137A (ja) | 2000-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008765A1 (es) | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del | |
| CO4890856A1 (es) | CICATRIZACION DE FRACTURAS USANDO ANALOGOS DE PTHrP | |
| CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
| DK2204187T3 (da) | Human influenzavaccine indeholdende fire influenzapeptider | |
| CO4790174A1 (es) | Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen | |
| ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| RS51602B (sr) | April receptor (bcma) i njegova upotreba | |
| HUP0003314A2 (hu) | GLP-1 analógok és származékok alkalmazása elhízás szabályozására használható gyógyszerkészítmények előállítására | |
| ES2187756T3 (es) | Uso de una composicion farmaceutica que comprende un peptido supresor del apetito. | |
| CO5170453A1 (es) | Composiciones farmaceuticas que comprenden acido (-)(3-trihalometoxi) (4-halofenil) acetico y metformina | |
| ES2052729T3 (es) | Un procedimiento para aplicar un revestimiento compuesto a un sustrato. | |
| HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| AR002024A1 (es) | Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas. | |
| HK1040738A1 (en) | Human parathyroid hormone modifications, preparation and use | |
| BR9807618A (pt) | Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa. | |
| AR013529A1 (es) | Rantes amino-terminalmente truncado, moleculas de adn, vector de expresion, celula huesped, proceso recombinante para prepararlo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende. | |
| AR008094A1 (es) | Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica. | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| AR024742A1 (es) | DERIVADOS CICLOPEPTIDICOS QUE ACTUAN COMO INHIBIDORES DE LA INTEGRINA ALFA v BETA 6, LOS MEDICAMENTOS A BASE DE ESTOS COMPUESTOS, LAS COMPOSICIONESFARMACEUTICAS QUE CONTIENEN AL MENOS UNO DE ESTOS MEDICAMENTOS, Y EL EMPLEO DE ESTOS PEPTIDOS PARA PREPARAR UN MEDICAMENTO. | |
| ATE365542T1 (de) | Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels | |
| ES2133295T3 (es) | Peptidos ciclicos y su uso. | |
| DK527187D0 (da) | Gonadoliberin-analoge, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
| AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. | |
| EP0717752A4 (en) | THERAPEUTIC COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |